These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16816373)

  • 41. L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.
    Falkowska E; Durso RJ; Gardner JP; Cormier EG; Arrigale RA; Ogawa RN; Donovan GP; Maddon PJ; Olson WC; Dragic T
    J Gen Virol; 2006 Sep; 87(Pt 9):2571-2576. PubMed ID: 16894195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.
    Guo Y; Feinberg H; Conroy E; Mitchell DA; Alvarez R; Blixt O; Taylor ME; Weis WI; Drickamer K
    Nat Struct Mol Biol; 2004 Jul; 11(7):591-8. PubMed ID: 15195147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.
    Dos Santos Á; Hadjivasiliou A; Ossa F; Lim NK; Turgut A; Taylor ME; Drickamer K
    Protein Sci; 2017 Feb; 26(2):306-316. PubMed ID: 27859859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of polymorphism in dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related (DC-SIGNR) gene on HIV-1 trans-infection.
    Zhu D; Kawana-Tachikawa A; Iwamoto A; Kitamura Y
    Biochem Biophys Res Commun; 2010 Mar; 393(4):598-602. PubMed ID: 20152818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Branched oligosaccharide structures on HBV prevent interaction with both DC-SIGN and L-SIGN.
    Op den Brouw ML; de Jong MA; Ludwig IS; van der Molen RG; Janssen HL; Geijtenbeek TB; Woltman AM
    J Viral Hepat; 2008 Sep; 15(9):675-83. PubMed ID: 18482282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.
    Dakappagari N; Maruyama T; Renshaw M; Tacken P; Figdor C; Torensma R; Wild MA; Wu D; Bowdish K; Kretz-Rommel A
    J Immunol; 2006 Jan; 176(1):426-40. PubMed ID: 16365436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo.
    Geijtenbeek TB; Groot PC; Nolte MA; van Vliet SJ; Gangaram-Panday ST; van Duijnhoven GC; Kraal G; van Oosterhout AJ; van Kooyk Y
    Blood; 2002 Oct; 100(8):2908-16. PubMed ID: 12351402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.
    Gramberg T; Hofmann H; Möller P; Lalor PF; Marzi A; Geier M; Krumbiegel M; Winkler T; Kirchhoff F; Adams DH; Becker S; Münch J; Pöhlmann S
    Virology; 2005 Sep; 340(2):224-36. PubMed ID: 16051304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.
    Marzi A; Möller P; Hanna SL; Harrer T; Eisemann J; Steinkasserer A; Becker S; Baribaud F; Pöhlmann S
    J Infect Dis; 2007 Nov; 196 Suppl 2(Suppl 2):S237-46. PubMed ID: 17940955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The association of genetic polymorphism of dendritic cell-specific ICAM-grabbing nonintegrin and hepatitis C infection].
    Wang M; Han HX; Lu J; Liu SY; Jiang Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):645-8. PubMed ID: 19785948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13.
    Soilleux EJ; Barten R; Trowsdale J
    J Immunol; 2000 Sep; 165(6):2937-42. PubMed ID: 10975799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques.
    Jameson B; Baribaud F; Pöhlmann S; Ghavimi D; Mortari F; Doms RW; Iwasaki A
    J Virol; 2002 Feb; 76(4):1866-75. PubMed ID: 11799181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Glycoprotein-Mediated Entry of Severe Fever with Thrombocytopenia Syndrome Virus.
    Tani H; Shimojima M; Fukushi S; Yoshikawa T; Fukuma A; Taniguchi S; Morikawa S; Saijo M
    J Virol; 2016 Jun; 90(11):5292-5301. PubMed ID: 26984731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.
    Marzi A; Akhavan A; Simmons G; Gramberg T; Hofmann H; Bates P; Lingappa VR; Pöhlmann S
    J Virol; 2006 Jul; 80(13):6305-17. PubMed ID: 16775318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and decrease of viral loads.
    Ezzikouri S; Rebbani K; Fakhir FZ; Alaoui R; Nadir S; Diepolder H; Thursz M; Khakoo SI; Benjelloun S
    Clin Microbiol Infect; 2014 May; 20(5):O325-32. PubMed ID: 24283933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis.
    Na H; Liu X; Li X; Zhang X; Wang Y; Wang Z; Yuan M; Zhang Y; Ren S; Zuo Y
    J Hematol Oncol; 2017 Jan; 10(1):28. PubMed ID: 28109307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of p38 MAPK pathway by hepatitis C virus E2 in cells transiently expressing DC-SIGN.
    Chen QL; Zhu SY; Bian ZQ; Zhao LJ; Cao J; Pan W; Qi ZT
    Cell Biochem Biophys; 2010; 56(1):49-58. PubMed ID: 19851890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection.
    Halary F; Amara A; Lortat-Jacob H; Messerle M; Delaunay T; Houlès C; Fieschi F; Arenzana-Seisdedos F; Moreau JF; Déchanet-Merville J
    Immunity; 2002 Nov; 17(5):653-64. PubMed ID: 12433371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of the tandem-repeat polymorphisms in DC-SIGNR alleles among drug users population with or without HIV/HCV infection].
    Zhao J; Zhao GL; Ma ZL; Wu XB; Feng TJ; Shi XD; Wang XH; Wang H; Zhu TF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):901-5. PubMed ID: 19141225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Dhole TN
    J Clin Immunol; 2008 Jan; 28(1):50-7. PubMed ID: 17876530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.